The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Use Epidural Steroid Injections Cautiously in Patients with Fracture Risk

Use Epidural Steroid Injections Cautiously in Patients with Fracture Risk

January 22, 2018 • By Scott Baltic

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Use of epidural steroid injections (ESIs) “should be approached with prudence,” particularly in patients who are at risk for osteoporotic fractures, such as women of postmenopausal age, according to authors of a systematic review.

You Might Also Like
  • Bone Mineral Density Most Important Determinant of Fracture Risk
  • Denosumab Dosing Delays Tied to Increased Fracture Risk
  • Bisphosphonates May Limit Fracture Risk in Users of Oral Glucocorticoids

Although the literature presents a mixed picture, ESIs in doses as low as 80 mg methylprednisolone equivalents seem to reduce bone mineral density (BMD), both locally (in the lumbar spine) and systemically (in the femoral neck), and ESIs also increase the risk of vertebral fracture, the researchers conclude. They recommend that use of an anti-osteoporotic medication be considered before giving an ESI.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The authors believe that their report, published online Jan. 2 in Pain Medicine, is the first systematic review of all available studies about ESIs’ effects on BMD and vertebral fracture risk.1

“The risk of fracture suggested by these studies is overall quite small, likely not outweighing the potential benefits from pain relief provided by these injections for the majority of patients,” corresponding author Dr. Mohamad Bydon of Mayo Clinic in Rochester, Minn., tells Reuters Health by email.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Nonetheless, he adds, “at this time, there is not enough evidence to provide clinical practice guidelines recommending which patients with known risk factors for diminished BMD are safe candidates for repeated ESIs.”

The new review encompassed eight studies involving 7,233 patients (mean ages, 49 to 74) with average follow-ups of 6 to 60 months. The steroids included triamcinolone, dexamethasone and methylprednisolone; the mean number of injections ranged from 1 to 14.7, with an average cumulative dose between 80 mg and 8,130 mg of methylprednisolone equivalents.

“Significant reductions in BMD” were associated with a cumulative methylprednisolone equivalents dose of 200 mg over one year and 400 mg over three years. However, such reductions were not found with methylprednisolone equivalent doses of <200 mg for postmenopausal women or of at least 3 grams for healthy men.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Overall, the risk of osteopenia and osteoporosis was lower in patients who were also receiving anti-osteoporotic medication.

The report also notes that the reviewed studies “suggest that adverse outcomes in terms of vertebral fracture risk or compromised BMD may differ considerably between men and women, although this has never been directly studied.”

To mitigate systemic effects, including fracture risk, several institutions, including the Mayo Clinic, do not administer more than three to four spinal injections in a given year, Dr. Bydon says.

In discussions with patients about the risks, benefits and alternative to ESIs, he adds, “factors such as older age, low bone density, or history of fracture should be considered. … But if over-administration of steroid increases the risk of injury, such as fracture, we may need to consider which patients are at higher risk for adverse outcomes with repeated doses of steroid.”

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: bone mineral density (BMD), epidural steroid injections, fracture risk, Fractures, Osteoporosis

You Might Also Like:
  • Bone Mineral Density Most Important Determinant of Fracture Risk
  • Denosumab Dosing Delays Tied to Increased Fracture Risk
  • Bisphosphonates May Limit Fracture Risk in Users of Oral Glucocorticoids
  • Higher Fracture Risk in Patients with Polymyalgia Rheumatica, Giant-Cell Arteritis

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.